CG Oncology Inc. Common s... (CGON)
undefined
undefined%
At close: undefined
30.52
0.07%
After-hours Jan 03, 2025, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21
Revenue 204.00K 191.00K 10.36M
Cost of Revenue n/a 15.00K 10.00K
Gross Profit 204.00K 176.00K 10.35M
Operating Income -55.45M -35.25M -12.61M
Interest Income n/a n/a n/a
Pretax Income -48.61M -35.44M -12.84M
Net Income -48.61M -35.44M -12.84M
Selling & General & Admin 9.90M 6.39M 4.63M
Research & Development 45.75M 29.03M 18.32M
Other Expenses n/a -196.00K 218.00K
Operating Expenses 55.65M 35.42M 22.95M
Interest Expense n/a 1K 451.00K
Selling & Marketing Expenses n/a -15.00K -10.00K
Cost & Expenses 55.65M 35.44M 22.96M
Income Tax n/a n/a n/a
Shares Outstanding (Basic) 4.33M 66.64M 66.64M
Shares Outstanding (Diluted) 4.33M 66.64M 66.64M
EPS (Basic) -15.65 -0.53 -0.19
EPS (Diluted) -15.65 -0.53 -0.19
EBITDA -55.43M -35.23M -12.38M
Depreciation & Amortization 17.00K 15.00K 10.00K